Open AccessAkt/mTOR and AMPK signaling pathways are responsible for liver X receptor agonist GW3965-enhanced gefitinib sensitivity in non-small cell lung cancer cell lines
Author(s) -
Qingbo Wang,
Bo Shen,
Xingzhen Qin,
Siwen Liu,
Jifeng Feng
Publication year - 2019
Publication title -
translational cancer research
Language(s) - English
Resource type - Journals
eISSN - 2219-6803
pISSN - 2218-676X
DOI - 10.21037/tcr.2018.12.34
Subject(s) - gefitinib , pi3k/akt/mtor pathway , autophagy , ampk , protein kinase b , cancer research , viability assay , signal transduction , apoptosis , cell growth , rptor , chemistry , medicine , microbiology and biotechnology , biology , cancer , epidermal growth factor receptor , kinase , protein kinase a , biochemistry